Due to signaling complexities and an increasing trend in anticancer drug resistance, a molecular target that plays a central role in diverse oncogenic signaling pathways has been investigated ( 43 ).
← all excerpts
Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non-small cell lung carcinoma cells.
1
—
—